Akceacanada - Latest News 2026-07-22T17:22:37+00:00 urn:uuid:7601aaf3-a372-5f5f-1432-8ec543bd1ece Akcea and Ionis Announce Publication of Long-Term Clinical Data of TEGSEDI® in Patients with Polyneuropathy Driven by hATTR Amyloidosis urn:uuid:52e7e358-3040-18b8-cc86-10f48366afe5 2020-12-28T08:11:11+00:00 Akcea Therapeutics Canada Confirms Letter of Intent with Pan-Canadian Pharmaceutical Alliance for TEGSEDI™ (inotersen injection) urn:uuid:0ae2aa3b-048e-1e45-85bd-d5adb7de6cb6 2020-11-19T12:04:15+00:00